Indian Drug Makers Augment HCQ Production Despite Export Ban, an Industrial Info Market Brief

Indian pharmaceutical manufacturers seem to be unmoved by the recent government-imposed ban on the export of the antimalarial drug hydroxychloriquine (HCQs), and continue with their capacity augmentation plans. Many Indian manufacturers, who had discontinued production of the HCQ active ingredient and its formulations due to low demand, have started rebuilding their capacity.